Microneedle arrays delivery of the conventional vaccines based on nonvirulent viruses

References

• Al-Zahrani S, Zaric M, McCrudden C, et al. (2012). Microneedle-mediated vaccine delivery: harnessing cutaneous immunobiology to improve efficacy. Expert Opin Drug Deliv 9:541–50
   PubMed Web of Science ®Google Scholar
• Alkilani AZ, McCrudden MT, Donnelly RF. (2015). Transdermal drug delivery: innovative pharmaceutical developments based on disruption of the barrier properties of the stratum corneum. Pharmaceutics 7:438–70
   PubMed Web of Science ®Google Scholar
• Anand A, Zaman K, Estivariz CF, et al. (2015). Early priming with inactivated poliovirus vaccine (IPV) and intradermal fractional dose IPV administered by a microneedle device: a randomized controlled trial. Vaccine 33:6816–22
   PubMed Web of Science ®Google Scholar
• Arya J, Prausnitz MR. (2015). Microneedle patches for vaccination in developing countries. J Control Release. [Epub ahead of print]. doi:10.1016/j.jconrel.2015.11.019
   PubMed Web of Science ®Google Scholar
• Bachy V, Hervouet C, Becker PD, et al. (2013). Langerin negative dendritic cells promote potent CD8+ T-cell priming by skin delivery of live adenovirus vaccine microneedle arrays. Proc Natl Acad Sci USA 110:3041–6
   PubMed Web of Science ®Google Scholar
• Barnes E, Folgori A, Capone S, et al. (2012). Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man. Sci Transl Med 4:115ra111
   Web of Science ®Google Scholar
• Becker PD, Hervouet C, Mason GM, et al. (2015). Skin vaccination with live virus vectored microneedle arrays induce long lived CD8(+) T cell memory. Vaccine 33:4691–8
   PubMed Web of Science ®Google Scholar
• Butler D. (2015). Measles by the numbers: a race to eradication. Nature 518:148–9
   PubMed Web of Science ®Google Scholar
• Bystrova S, Luttge R. (2011). Micromolding for ceramic microneedle arrays. Microelectron Eng 88:1681–4
   Web of Science ®Google Scholar
• Carey JB, Pearson FE, Vrdoljak A, et al. (2013). Microneedle array design determines the induction of protective memory CD8+ T cell responses induced by a recombinant live malaria vaccine in mice. PLoS One 6:e22442
   Web of Science ®Google Scholar
• Carey JB, Vrdoljak A, O’Mahony C, et al. (2014). Microneedle-mediated immunization of an adenovirus-based malaria vaccine enhances antigen-specific antibody immunity and reduces anti-vector responses compared to the intradermal route. Sci Rep 4:6154
   PubMed Web of Science ®Google Scholar
• Chen D, Zehrung D. (2012). Desirable attributes of vaccines for deployment in low-resource settings. J Pharm Sci 102:29–33
   PubMed Web of Science ®Google Scholar
• Cheung K, Das DB. (2016). Microneedles for drug delivery: trends and progress. Drug Deliv. [Epub ahead of print]. doi:10.3109/10717544.2014.986309
   PubMed Web of Science ®Google Scholar
• Childress BC, Montney JD, Albro EA. (2014). Making evidence-based selections of influenza vaccines. Hum Vaccin Immunother 10:2729–32
   PubMed Web of Science ®Google Scholar
• Chu LY, Ye L, Dong K, et al. (2016). Enhanced stability of inactivated influenza vaccine encapsulated in dissolving microneedle patches. Pharm Res 33:868–78
   PubMed Web of Science ®Google Scholar
• de Cassan SC, Draper SJ. (2013). Recent advances in antibody-inducing poxviral and adenoviral vectored vaccine delivery platforms for difficult disease targets. Expert Rev Vaccines 12:365–78
   PubMed Web of Science ®Google Scholar
• DeMuth PC, Li AV, Abbink P, et al. (2013). Vaccine delivery with microneedle skin patches in nonhuman primates. Nat Biotechnol 31:1082–5
   PubMed Web of Science ®Google Scholar
• Depelsenaire AC, Meliga SC, McNeilly CL, et al. (2014). Colocalization of cell death with antigen deposition in skin enhances vaccine immunogenicity. J Invest Dermatol 134:2361–70
   PubMed Web of Science ®Google Scholar
• Domingues CM, de Fatima Pereira S, Cunha Marreiros AC, et al. (2014). Introduction of sequential inactivated polio vaccine-oral polio vaccine schedule for routine infant immunization in Brazil’s national immunization program. J Infect Dis 210:S143–1
   PubMed Web of Science ®Google Scholar
• Donnelly RF, Majithiya R, Singh TRR, et al. (2011). Design, optimization and characterisation of polymeric microneedle arrays prepared by a novel laser-based micromoulding technique. Pharmaceut Res 28:41–57
   PubMed Web of Science ®Google Scholar
• Donnelly RF, Raj Singh TR, Woolfson AD. (2010). Microneedle-based drug delivery systems: microfabrication, drug delivery, and safety. Drug Deliv 17:187–207
   PubMed Web of Science ®Google Scholar
• Dormitzer PR. (2015). Rapid production of synthetic influenza vaccines. Curr Top Microbiol Immunol 386:237–73
   PubMed Web of Science ®Google Scholar
• Draper SJ, Heeney JL. (2010). Viruses as vaccine vectors for infectious diseases and cancer. Nat Rev Microbiol 8:62–73
   PubMed Web of Science ®Google Scholar
• Edens C, Collins ML, Ayers J, et al. (2013). Measles vaccination using a microneedle patch. Vaccine 31:3403–9
   PubMed Web of Science ®Google Scholar
• Edens C, Collins ML, Goodson JL, et al. (2015). A microneedle patch containing measles vaccine is immunogenic in non-human primates. Vaccine 33:4712–18
   PubMed Web of Science ®Google Scholar
• Galazka A, Milstien J, Zaffran M. (1998). Thermostability of vaccines. In: The global programme for vaccines and immunization. Geneva Switzerland: World Health Organization, 2–4
   Google Scholar
• Haq MI, Smith E, John DN, et al. (2009). Clinical administration of microneedles: skin puncture, pain and sensation. Biomed Microdevices 11:35–47
   PubMed Web of Science ®Google Scholar
• Henry S, McAllister DV, Allen MG, Prausnitz MR. (1998). Microfabricated microneedles: a novel approach to transdermal drug delivery. J Pharmaceut Sci 87:922–5
   PubMed Web of Science ®Google Scholar
• Hirobe S, Azukizawa H, Hanafusa T, et al. (2015). Clinical study and stability assessment of a novel transcutaneous influenza vaccination using a dissolving microneedle patch. Biomaterials 57:50–8
   PubMed Web of Science ®Google Scholar
• Hirobe S, Azukizawa H, Matsuo K, et al. (2013). Development and clinical study of a self-dissolving microneedle patch for transcutaneous immunization device. Pharm Res 30:2664–74
   PubMed Web of Science ®Google Scholar
• Hotez PJ, Bottazzi ME, Strych U. (2016). New vaccines for the world’s poorest people. Annu Rev Med 67:405–17
   PubMed Web of Science ®Google Scholar
• Jacoby E, Jarrahian C, Hull HF, Zehrung D. (2015). Opportunities and challenges in delivering influenza vaccine by microneedle patch. Vaccine 33:4699–704
   PubMed Web of Science ®Google Scholar
• Kim YC, Park JH, Prausnitz MR. (2012). Microneedles for drug and vaccine delivery. Adv Drug Deliv Rev 64:1547–68
   PubMed Web of Science ®Google Scholar
• Kolli CS. (2015). Microneedles: bench to bedside. Ther Deliv 6:1081–8
   PubMedGoogle Scholar
• Korschun H. (2015). Clinical study at Emory tests microneedle skin patches as alternative to flu shot, Researchers are enrolling volunteers in a clinical study at the Hope Clinic of the Emory Vaccine Center. Woodruff Health Sciences Center, Emory University
   Google Scholar
• Laurent PE, Bourhy H, Fantino M, et al. (2010). Safety and efficacy of novel dermal and epidermal microneedle delivery systems for rabies vaccination in healthy adults. Vaccine 28:5850–6
   PubMed Web of Science ®Google Scholar
• Lee BY, Bartsch SM, Mvundura M, et al. (2015). An economic model assessing the value of microneedle patch delivery of the seasonal influenza vaccine. Vaccine 33:4727–36
   PubMed Web of Science ®Google Scholar
• Levin Y, Kochba E, Kenney R. (2014). Clinical evaluation of a novel microneedle device for intradermal delivery of an influenza vaccine: are all delivery methods the same? Vaccine 32:4249–52
   PubMed Web of Science ®Google Scholar
• Levine MM. (2011). “IDEAL” vaccines for resource poor settings. Vaccine 29:D116–25
   PubMed Web of Science ®Google Scholar
• Low N, Bavdekar A, Jeyaseelan L, et al. (2015). A randomized, controlled trial of an aerosolized vaccine against measles. N Engl J Med 372:1519–29
   PubMed Web of Science ®Google Scholar
• Lutton RE, Moore J, Larraneta E, et al. (2015). Microneedle characterisation: the need for universal acceptance criteria and GMP specifications when moving towards commercialisation. Drug Deliv Transl Res 5:313–31
   PubMed Web of Science ®Google Scholar
• Marichal T, Ohata K, Bedoret D, et al. (2011). DNA released from dying host cells mediates aluminum adjuvant activity. Nat Med 17:996–1002
   PubMed Web of Science ®Google Scholar
• Marshall S, Sahm LJ, Moore AC. (2016). Microneedle technology for immunisation: perception, acceptability and suitability for paediatric use. Vaccine 34:723–34
   PubMed Web of Science ®Google Scholar
• Martanto W, Davis SP, Holiday NR, et al. (2004). Transdermal delivery of insulin using microneedles in vivo. Pharm Res 21:947–52
   PubMed Web of Science ®Google Scholar
• Matzinger P. (1994). Tolerance, danger, and the extended family. Annu Rev Immunol 12:991–1045
   PubMed Web of Science ®Google Scholar
• Meek G. (2015). Microneedle patch for measles vaccination could be a game changer, promises to increase reach of immunization coverage globally. CDC Newsroom Releases
   Google Scholar
• Melzack R. (1987). The short-form McGill pain questionnaire. Pain 30:191–7
   PubMed Web of Science ®Google Scholar
• Merkle HP. (2015). Drug delivery’s quest for polymers: where are the frontiers? Eur J Pharm Biopharm 97:293–303
   PubMed Web of Science ®Google Scholar
• Mikszta JA, Alarcon JB, Brittingham JM, et al. (2002). Improved genetic immunization via micromechanical disruption of skin-barrier function and targeted epidermal delivery. Nat Med 8:415–19
   PubMed Web of Science ®Google Scholar
• Mistilis MJ, Bommarius AS, Prausnitz MR. (2015). Development of a thermostable microneedle patch for influenza vaccination. J Pharmaceut Sci 104:740–9
   PubMed Web of Science ®Google Scholar
• Neutra MR, Kozlowski PA. (2006). Mucosal vaccines: the promise and the challenge. Nat Rev Immunol 6:148–58
   PubMed Web of Science ®Google Scholar
• Norman JJ, Arya JM, McClain MA, et al. (2014). Microneedle patches: usability and acceptability for self-vaccination against influenza. Vaccine 32:1856–62
   PubMed Web of Science ®Google Scholar
• Obar JJ, Lefrancois L. (2010). Early events governing memory CD8+ T-cell differentiation. Int Immunol 22:619–25
   PubMed Web of Science ®Google Scholar
• Ozawa S, Mirelman A, Stack ML, et al. (2012). Cost-effectiveness and economic benefits of vaccines in low- and middle-income countries: a systematic review. Vaccine 31:96–108
   PubMed Web of Science ®Google Scholar
• Park JH, Allen MG, Prausnitz MR. (2005). Biodegradable polymer microneedles: fabrication, mechanics and transdermal drug delivery. J Control Release 104:51–66
   PubMed Web of Science ®Google Scholar
• Pattani A, McKay PF, Garland MJ, et al. (2012). Microneedle mediated intradermal delivery of adjuvanted recombinant HIV-1 CN54gp140 effectively primes mucosal boost inoculations. J Control Release 162:529–37
   PubMed Web of Science ®Google Scholar
• Pearton M, Kang SM, Song JM, et al. (2010). Influenza virus-like particles coated onto microneedles can elicit stimulatory effects on Langerhans cells in human skin. Vaccine 28:6104–13
   PubMed Web of Science ®Google Scholar
• Prausnitz MR, Mikszta JA, Cormier M, Andrianov AK. (2009). Microneedle-based vaccines. Curr Top Microbiol Immunol 333:369–93
   PubMedGoogle Scholar
• Qin D, Xia Y, Whitesides GM. (2010). Soft lithography for micro- and nanoscale patterning. Nat Protoc 5:491–502
   PubMed Web of Science ®Google Scholar
• Qiu Y, Guo L, Zhang S, et al. (2016). DNA-based vaccination against hepatitis B virus using dissolving microneedle arrays adjuvanted by cationic liposomes and CpG ODN. Drug Deliv. [Epub ahead of print]. doi:10.3109/10717544.2014.992497
   PubMed Web of Science ®Google Scholar
• Resik S, Tejeda A, Sutter RW, et al. (2013). Priming after a fractional dose of inactivated poliovirus vaccine. N Engl J Med 368:416–24
   PubMed Web of Science ®Google Scholar
• Sarkar S, Kalia V, Haining WN, et al. (2008). Functional and genomic profiling of effector CD8 T cell subsets with distinct memory fates. J Exp Med 205:625–40
   PubMed Web of Science ®Google Scholar
• Shin JH, Park JK, Lee DH, et al. (2015). Microneedle vaccination elicits superior protection and antibody response over intranasal vaccination against swine-origin influenza A (H1N1) in mice. PLoS One 10:e0130684
   PubMed Web of Science ®Google Scholar
• Suh H, Shin J, Kim YC. (2014). Microneedle patches for vaccine delivery. Clin Exp Vaccine Res 3:42–9
   PubMedGoogle Scholar
• Toon J. (2015). Polio vaccination with microneedle patches receives funding for patch development, clinical trial, clinical trial will evaluate polio vaccination using microneedle patch. Atlanta (GA): Georgia Institute of Technology News Center, Georgia Institute of Technology
   Google Scholar
• van Damme P, Oosterhuis-Kafeja F, Van der Wielen M, et al. (2009). Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults. Vaccine 27:454–9
   PubMed Web of Science ®Google Scholar
• van der Maaden K, Jiskoot W, Bouwstra J. (2012). Microneedle technologies for (trans)dermal drug and vaccine delivery. J Control Release 161:645–55
   PubMed Web of Science ®Google Scholar
• van der Maaden K, Sekerdag E, Schipper P, et al. (2015). Layer-by-layer assembly of inactivated poliovirus and n-trimethyl chitosan on ph-sensitive microneedles for dermal vaccination. Langmuir 31:8654–60
   PubMed Web of Science ®Google Scholar
• Wang J, Li B, Wu MX. (2015a). Effective and lesion-free cutaneous influenza vaccination. Proc Natl Acad Sci USA 112:5005–10
   PubMed Web of Science ®Google Scholar
• Wang J, Shah D, Chen XY, et al. (2014a). A micro-sterile inflammation array as an adjuvant for influenza vaccines. Nat Commun 5:4447.
   PubMed Web of Science ®Google Scholar
• Wang N, Wang T, Zhang M, et al. (2014b). Using procedure of emulsification-lyophilization to form lipid A-incorporating cochleates as an effective oral mucosal vaccine adjuvant-delivery system (VADS). Int J Pharm 468:39–49
   PubMed Web of Science ®Google Scholar
• Wang N, Wang T, Zhang ML, et al. (2014c). Mannose derivative and lipid A dually decorated cationic liposomes as an effective cold chain free oral mucosal vaccine adjuvant-delivery system. Eur J Pharm Biopharm 88:194–206
   PubMed Web of Science ®Google Scholar
• Wang T, Wang N. (2015). Biocompatible mater constructed microneedle arrays as a novel vaccine adjuvant-delivery system for cutaneous and mucosal vaccination. Curr Pharm Design 21:5245–55
   PubMed Web of Science ®Google Scholar
• Wang T, Zhen Y, Ma X, et al. (2015b). Mannosylated and lipid A-incorporating cationic liposomes constituting microneedle arrays as an effective oral mucosal HBV vaccine applicable in the controlled temperature chain. Colloids Surf B Biointerfaces 126:520–30
   PubMed Web of Science ®Google Scholar
• Wang T, Zhen Y, Ma X, et al. (2015c). Phospholipid bilayer-coated aluminum nanoparticles as an effective vaccine adjuvant-delivery system. ACS Appl Mater Interfaces 7:6391–6
   PubMed Web of Science ®Google Scholar
• Wang T, Zhen YY, Ma XY, et al. (2015d). Mannosylated and lipid A-incorporating cationic liposomes constituting microneedle arrays as an effective oral mucosal HBV vaccine applicable in the controlled temperature chain. Colloid Surface B Biointerfaces 126:520–30
   PubMed Web of Science ®Google Scholar
• Wendorf JR, Ghartey-Tagoe EB, Williams SC, et al. (2011). Transdermal delivery of macromolecules using solid-state biodegradable microstructures. Pharm Res 28:22–30
   PubMed Web of Science ®Google Scholar
• Wilke N, Mulcahy A, Ye SR, Morrissey A. (2005). Process optimization and characterization of silicon microneedles fabricated by wet etch technology. Microelectron J 36:650–6
   Web of Science ®Google Scholar
• Yang S, Feng Y, Zhang L, et al. (2012). A scalable fabrication process of polymer microneedles. Int J Nanomed 7:1415–22
   PubMed Web of Science ®Google Scholar
• Zhen YY, Wang N, Gao ZB, et al. (2015). Multifunctional liposomes constituting microneedles induced robust systemic and mucosal immunoresponses against the loaded antigens via oral mucosal vaccination. Vaccine 33:4330–40
   PubMed Web of Science ®Google Scholar
• Zipursky S, Djingarey MH, Lodjo JC, et al. (2014). Benefits of using vaccines out of the cold chain: delivering meningitis A vaccine in a controlled temperature chain during the mass immunization campaign in Benin. Vaccine 32:1431–5
   PubMed Web of Science ®Google Scholar